History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In 1876, von Kupffer described liver Sternzellen (star-shaped cells). The functions of these cells remained enigmatic for 75 years until Ito observed lipid-containing perisinusoidal cells in human liver. In 1971, Wake demonstrated that the Sternzellen of von Kupffer and the fat-storing cells described by Ito were identical. Wake also established that these cells were important sites of vitamin A storage. Soon thereafter, Kent and Popper demonstrated that the stellate cells were intimately linked to the pathogenesis of hepatic fibrosis. Since then, these cells have been studied in detail. Quiescent stellate cells represent 5-8% of the total number of liver cells. They play a cardinal role in storage and controlled release of retinoids. They control extracellular matrix (ECM) turnover in the space of Disse by secreting the correct amounts of a limited number of ECM molecules, and by releasing matrix metalloproteinases and their inhibitors. By virtue of their long cytoplasmic processes, quiescent stellate cells presumably contribute to the control of blood flow through the sinusoidal capillaries. They are important sources of paracrine, autocrine, juxtacrine, and chemoattractant factors that maintain homeostasis in the microenvironment of the hepatic sinusoid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the healthy liver, HSCs are in a quiescent state (qHSCs), in which they store large amounts of retinoids in the form of retinyl esters [16, 221].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [16]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Items 101–200 of 734
A Cell-type-resolved Liver Proteome
Ding, C., Li, Y., Guo, F., Jiang, Y., Ying, W., Li, D., Yang, D., Xia, X., Liu, W., Zhao, Y., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060145 · Cited by 124
Radaeva, S., Wang, L., Radaev, S., Jeong, W.-I., Park, O., & Gao, B. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00212.2007 · Cited by 123
The roles and mechanisms of hypoxia in liver fibrosis
Cai, J., Hu, M., Chen, Z., & Ling, Z. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02854-x · Cited by 152
Buchholz, M., Kestler, H. A., Holzmann, K., Ellenrieder, V., Schneiderhan, W., Siech, M., Adler, G., Bachem, M. G., & Gress, T. M. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0680-2 · Cited by 124
Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
Kitano, M., & Bloomston, P. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030038 · Cited by 121
Stellate cells: A moving target in hepatic fibrogenesis†
Friedman, S. L. (2004) · Hepatology · doi:10.1002/hep.20476 · Cited by 121
Svegliati‐Baroni, G., De Minicis, S., & Marzioni, M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01825.x · Cited by 119
Natural killer cells and liver fibrosis
Fasbender, F., Widera, A., Hengstler, J. G., & Watzl, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00019 · Cited by 118
“They were described by Karl Wilhelm von Kupffer in 1876, but their role in liver disease was only identified in the 1980s (47).”
BackgroundBartley, P. B., Ramm, G. A., Jones, M. K., Ruddell, R. G., Li, Y. S., & McManus, D. P. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2006.04.015 · Cited by 128
Hypoxia-induced angiogenesis in human hepatocellular carcinoma
Kim, K.-R., Moon, H.-E., & Kim, K. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0380-0 · Cited by 122
Clinical and surgical anatomy of the liver: A review for clinicians
Juza, R. M., & Pauli, E. M. (2014) · Clinical Anatomy · doi:10.1002/ca.22350 · Cited by 117
Origin of myofibroblasts in liver fibrosis
Brenner, D. A., Kisseleva, T., Scholten, D., Paik, Y. H., Iwaisako, K., Inokuchi, S., Schnabl, B., Seki, E., De Minicis, S., Oesterreicher, C., et al. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s17 · Cited by 116
Jalan, R., Chiara, F. D., Vairappan, B., Andreola, F., Khetan, V. U., Malagó, M., Pinzani, M., Mookerjee, R. P., & Rombouts, K. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.019 · Cited by 130
Functional Immune Anatomy of the Liver—As an Allograft
Demetris, A. J., Bellamy, C. O. C., Gandhi, C. R., Prost, S., Nakanuma, Y., & Stolz, D. B. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13749 · Cited by 115
Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells
Carson, J. P., Ramm, G. A., Robinson, M. W., McManus, D. P., & Gobert, G. N. (2018) · Trends in Parasitology · doi:10.1016/j.pt.2018.02.005 · Cited by 120
Molecular basis of hepatic fibrosis
Hui, A. Y., & Friedman, S. L. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403005684 · Cited by 118
Spatiotemporal modeling of molecular holograms
Qiu, X., Zhu, D. Y., Lu, Y., Yao, J., Jing, Z., Min, K. H., Cheng, M., Pan, H., Zuo, L., King, S. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.10.011 · Cited by 150
Hepatocytes Express Nerve Growth Factor during Liver Injury
Oakley, F., Trim, N., Constandinou, C. M., Ye, W., Gray, A., Frantz, G. D., Hillan, K. J., Kendall, T. J., Benyon, R. C., Mann, D. A., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63544-4 · Cited by 113
Herrmann, J., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00060.x · Cited by 113
Stewart, R. K., Dangi, A., Huang, C., Murase, N., Kimura, S., Stolz, D. B., Wilson, G. C., Lentsch, A. B., & Gandhi, C. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.013 · Cited by 117
Modulation of hepatic stellate cells and reversibility of hepatic fibrosis
Huang, Y., Deng, X., & Liang, J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.038 · Cited by 122
Schwabe, R. F., & Brenner, D. A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01068-6 · Cited by 112
Intermediate filament cytoskeleton of the liver in health and disease
Strnad, P., Stumptner, C., Zatloukal, K., & Denk, H. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0431-x · Cited by 117
HDAC inhibitors in experimental liver and kidney fibrosis
Beneden, K. V., Mannaerts, I., Pauwels, M., Branden, C. V. D., & van Grunsven, L. A. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-1 · Cited by 112
Hepatic myofibroblasts: A heterogeneous population of multifunctional cells in liver fibrogenesis
Novo, E., di Bonzo, L. V., Cannito, S., Colombatto, S., & Parola, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.010 · Cited by 122
Hiasa, M., Matsumoto, T., Komatsu, T., & Moriyama, Y. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00090.2006 · Cited by 109
Understanding the heterogeneity of resident liver macrophages
Blériot, C., & Ginhoux, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02694 · Cited by 107
“They are mainly known for their vitamin A storage function at resting state (32) but they are also known to drive fibrosis by the production of extracellular matrix once activated and trans-differentiated into myofibroblasts (33).”
BackgroundHost Regulators of Liver Fibrosis During Human Schistosomiasis
Kamdem, S. D., Moyou‐Somo, R., Brombacher, F., & Nono, J. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02781 · Cited by 108
Zhu, J., Luo, Z., Pan, Y., Zheng, W., Li, W., Zhang, Z., Xiong, P., Xu, D., Du, M., Wang, B., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27656 · Cited by 106
siRNA- and miRNA-based therapeutics for liver fibrosis
Zhao, Z., Lin, C.-Y., & Cheng, K. (2019) · Translational Research · doi:10.1016/j.trsl.2019.07.007 · Cited by 106
Zisser, A., Ipsen, D. H., & Tveden-Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9040365 · Cited by 104
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
Chen, Z., Jain, A., Liu, H., Zhao, Z., & Cheng, K. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.256156 · Cited by 112
Moles, A., Tarrats, N., Fernández-Checa, J. C., & Marí, M. (2009) · Hepatology · doi:10.1002/hep.22753 · Cited by 105
MABUCHI, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.005 · Cited by 103
Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids
Hellemans, K., Verbuyst, P., Quartier, E., Schuit, F., Rombouts, K., Chandraratna, R. A. S., Schuppan, D., & Geerts, A. (2004) · Hepatology · doi:10.1002/hep.20015 · Cited by 102
Self-citationStellate Cells in Tissue Repair, Inflammation, and Cancer
Sherman, M. H. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062855 · Cited by 103
Liu, X., Wang, W., Hu, H., Tang, N., Zhang, C., Liang, W. P., & Wang, M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9043-5 · Cited by 104
Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells
Liu, Z., van Grunsven, L. A., Rossen, E. V., Schroyen, B., Timmermans, J., Geerts, A. E., & Reynaert, H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00477.x · Cited by 104
Self-citation(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Non‐invasive markers to predict the liver fibrosis in non‐alcoholic fatty liver disease
Lydatakis, H., Hager, I. P., Kostadelou, E., Mpousmpoulas, S., Pappas, S., & Diamantis, I. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01312.x · Cited by 97
Liver fibrosis in vitro: Cell culture models and precision-cut liver slices
van de Bovenkamp, M., Groothuis, G. M. M., Meijer, D. K. F., & Olinga, P. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.12.009 · Cited by 110
Han, Y.-P., Yan, C., Zhou, L., Qin, L., & Tsukamoto, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700554200 · Cited by 95
van de Bovenkamp, M., Groothuis, G. M. M., Draaisma, A. L., Merema, M. T., Bezuijen, J. I., van Gils, M. J., Meijer, D. K. F., Friedman, S. L., & Olinga, P. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi127 · Cited by 94
Lan, Q., & Han, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100011 · Cited by 100
Food components with antifibrotic activity and implications in prevention of liver disease
Bae, M., Park, Y., & Lee, J. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.003 · Cited by 101
Liu, G., Wei, C., Yuan, S., Zhang, Z., Li, J., Zhang, L., Wang, G., & Fang, L. (2022) · Phytotherapy Research · doi:10.1002/ptr.7558 · Cited by 104
Gressner, O. A., Weiskirchen, R., & Gressner, A. M. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00092.x · Cited by 103
In vitro reversion of activated primary human hepatic stellate cells
El Taghdouini, A., Najimi, M., Sancho-Bru, P., Sokal, E., & van Grunsven, L. A. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0031-z · Cited by 91
Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
Chen, L., Brenner, D. A., & Kisseleva, T. (2019) · Hepatology Communications · doi:10.1002/hep4.1290 · Cited by 91
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Tarry-Adkins, J. L., Fernandez-Twinn, D. S., Hargreaves, I. P., Neergheen, V., Aiken, C. E., Martin-Gronert, M. S., McConnell, J. M., & Ozanne, S. E. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.119834 · Cited by 89
Wu, J. H., Huang, J., Kuang, S., Chen, J., Li, M., Chen, B., Wang, J., Cheng, D., & Shuai, X. (2019) · Advanced Science · doi:10.1002/advs.201801809 · Cited by 93
Effect of Sea buckthorn on liver fibrosis: A clinical study
Gao, Z. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i7.1615 · Cited by 88
Oakley, F., Mann, J., Ruddell, R. G., Pickford, J., Weinmaster, G., & Mann, D. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211051200 · Cited by 88
Anti‐adipogenic regulation underlies hepatic stellate cell transdifferentiation
Tsukamoto, H., She, H., Hazra, S., Cheng, J., & Miyahara, T. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04573.x · Cited by 87
Mechanisms of hepatic fibrogenesis
Friedman, S. L. (2004) · Springer eBooks · doi:10.1007/978-94-007-1042-9_4 · Cited by 87
Starring stellate cells in liver immunology
Winau, F., Breunig, C., Darmoise, A., & Kaufmann, S. H. E. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.006 · Cited by 110
Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma
Bai, X., Wu, L., Liang, T., Liu, Z., Li, J., Li, D., Xie, H., Yin, S., Yu, J., Lin, Q., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0252-7 · Cited by 86
Hematopoietic origin of hepatic stellate cells in the adult liver
Miyata, E., Masuya, M., Yoshida, S., Nakamura, S., Kato, K., Sugimoto, Y., Shibasaki, T., Yamamura, K., Ohishi, K., Nishii, K., et al. (2008) · Blood · doi:10.1182/blood-2007-07-101261 · Cited by 85
On the origin of stellate cells: mesodermal, endodermal or neuro-ectodermal?
Geerts, A. E. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.006 · Cited by 95
Self-citationThe role of pancreatic stellate cells in pancreatic cancer
Moir, J. A. G., Mann, J., & White, S. A. (2015) · Surgical Oncology · doi:10.1016/j.suronc.2015.05.002 · Cited by 95
Arauz, J., Moreno, M. G., Cortés‐Reynosa, P., Salazar, E. P., & Muriel, P. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2788 · Cited by 84
Immunotherapy for hepatocellular carcinoma
Li, S., Yang, F., & Ren, X. (2015) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2015.01054 · Cited by 86
Rombouts, K., Kisanga, E. R., Hellemans, K., Wielant, A., Schuppan, D., & Geerts, A. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00051-5 · Cited by 91
Self-citationHepatic stellate cells do not derive from the neural crest
Cassiman, D. M., Barlow, A. J., Borght, S. V., Libbrecht, L. J., & Pachnis, V. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.023 · Cited by 90
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop
Martella, A., Silvestri, C., Maradonna, F., Gioacchini, G., Allarà, M., Radaelli, G., Overby, D. R., Marzo, V. D., & Carnevali, O. (2016) · Endocrinology · doi:10.1210/en.2015-1384 · Cited by 84
Martins, L. A. M., Coelho, B. P., Behr, G., Pettenuzzo, L. F., Souza, I. C. C., Moreira, J. C. F., Borojevic, R., Gottfried, C., & Guma, F. C. R. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9703-8 · Cited by 82
Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
Bazwinsky‐Wutschke, I., Zipprich, A., & Dehghani, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102516 · Cited by 93
Fucoidan partly prevents CCl4-induced liver fibrosis
Hayashi, S., Itoh, A., Isoda, K., Kondoh, M., Kawase, M., & Yagi, K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.015 · Cited by 81
Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
Gressner, O. A., Rizk, M. S., Kovalenko, E. P., Weiskirchen, R., & Gressner, A. M. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05345.x · Cited by 90
Debernardi-Venon, W., Martini, S., Biasi, F., Vizio, B., Termine, A., Poli, G., Brunello, F. G., Alessandria, C., Bonardi, R., Saracco, G. M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.017 · Cited by 86
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, L., Subramanian, P., & Hammerich, L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.010 · Cited by 80
Liang, D., Chen, H., Zhao, L., Zhang, W., Hu, J., Liu, Z., Zhong, P., Wang, W., Wang, J., & Liang, G. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.016 · Cited by 89
Molecular Pathogenesis of Alcohol‐Induced Hepatic Fibrosis
Siegmund, S., & Brenner, D. A. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000189275.97419.58 · Cited by 88
Glycosylation-mediated targeting of carriers
Kawakami, S., & Hashida, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.001 · Cited by 83
The Contribution of Non-Professional Antigen-Presenting Cells to Immunity and Tolerance in the Liver
Mehrfeld, C., Zenner, S., Kornek, M., & Lukacs-Kornek, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00635 · Cited by 78
Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis
Ezhilarasan, D. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30582 · Cited by 82
Dangi, A., Sumpter, T. L., Kimura, S., Stolz, D. B., Murase, N., Raimondi, G., Vodovotz, Y., Huang, C., Thomson, A. W., & Gandhi, C. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102460 · Cited by 77
Kong, W. H., Park, K., Lee, M. Y., Lee, H., Sung, D. K., & Hahn, S. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.067 · Cited by 77
Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2
Weiskirchen, R., Weimer, J., Meurer, S. K., Kron, A., Seipel, B., Vater, I., Arnold, N., Siebert, R., Xu, L., Friedman, S. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075692 · Cited by 76
Molecular Mechanisms of Alcohol-Induced Hepatic Fibrosis
Siegmund, S. V., Dooley, S., & Brenner, D. A. (2005) · Digestive Diseases · doi:10.1159/000090174 · Cited by 75
Application of Toxicogenomics to Toxicology: Basic Concepts in the Analysis of Microarray Data
Irwin, R. D., Boorman, G. A., Cunningham, M. L., Heinloth, A. N., Malarkey, D. E., & Paules, R. S. (2004) · Toxicologic Pathology · doi:10.1080/01926230490424752 · Cited by 76
El Taghdouini, A., Sørensen, A. L., Reiner, A. H., Coll, M., Verhulst, S., Mannaerts, I., Øie, C. I., Smedsrød, B., Najimi, M., Sokal, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4925 · Cited by 73
Adipogenic Phenotype of Hepatic Stellate Cells
Tsukamoto, H. (2005) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000189279.92602.f0 · Cited by 73
Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions
Uyama, N., Zhao, L., Rossen, E. V., Hirako, Y., Reynaert, H., Adams, D. H., Xue, Z., Li, Z., Robson, R., Pekny, M., et al. (2006) · Gut · doi:10.1136/gut.2005.078865 · Cited by 73
Self-citationSumpter, T. L., Dangi, A., Matta, B. M., Huang, C., Stolz, D. B., Vodovotz, Y., Thomson, A. W., & Gandhi, C. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200819 · Cited by 72
“Because HSCs make contact with almost all liver cell types via cytoplasmic extensions (30) and express immune regulatory molecules (32), their influence on cells of the innate and adaptive immune systems has attracted increasing attention (33, 38, 66).”
BackgroundMolecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Wang, F.-D., Zhou, J., & Chen, E.-Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 71
Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-β
Arauz, J., Zarco, N., Segovia, J., Shibayama, M., Tsutsumi, V., & Muriel, P. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283644e26 · Cited by 72
Maschmeyer, P., Flach, M., & Winau, F. (2011) · Journal of Visualized Experiments · doi:10.3791/2710 · Cited by 67
Bioprinting for Liver Transplantation
Kryou, C., Leva, C. V., Chatzipetrou, M., & Zergioti, I. (2019) · Bioengineering · doi:10.3390/bioengineering6040095 · Cited by 78
Retinyl ester hydrolases and their roles in vitamin A homeostasis
Schreiber, R., Taschler, U., Preiss-Landl, K., Wongsiriroj, N., Zimmermann, R., & Lass, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.001 · Cited by 70
Cell Signals Influencing Hepatic Fibrosis
Cong, M., Iwaisako, K., Jiang, C., & Kisseleva, T. (2012) · International Journal of Hepatology · doi:10.1155/2012/158547 · Cited by 77
Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity
Gupta, G., Khadem, F., & Uzonna, J. E. (2019) · Cytokine · doi:10.1016/j.cyto.2018.09.004 · Cited by 69
Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells
Orr, J. G., Leel, V., Cameron, G. A., Marek, C. J., Haughton, E. L., Elrick, L. J., Trim, J. E., Hawksworth, G. M., Halestrap, A. P., & Wright, M. C. (2004) · Hepatology · doi:10.1002/hep.20254 · Cited by 69
Rombouts, K., Knittel, T. E., Machesky, L. M., Braet, F., Wielant, A., Hellemans, K., Bleser, P. D., Gelman, I. H., Ramadori, G. P., & Geerts, A. E. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00275-1 · Cited by 73
Self-citationClass II HDAC Inhibition Hampers Hepatic Stellate Cell Activation by Induction of MicroRNA-29
Mannaerts, I., Eysackers, N., Onyema, O. O., Van Beneden, K., Valente, S., Mai, A., Odenthal, M., & van Grunsven, L. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055786 · Cited by 68
Casas‐Grajales, S., Ramos‐Tovar, E., Chávez-Estrada, E. J., Alvarez-Suarez, D. E., Hernández‐Aquino, E., Reyes‐Gordillo, K., Cerda-García-Rojas, C. M., Camacho, J., Tsutsumi, V., Lakshman, M. R., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.035 · Cited by 69
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65
Xuemin, W., Tang, X., Gong, X., Albanis, E., Friedman, S. L., & Mao, Z. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.007 · Cited by 69
Hellemans, K., Rombouts, K., Quartier, E., Dittié, A. S., Knorr, A., Michalik, L., Rogiers, V., Schuit, F., Wahli, W., & Geerts, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200376-jlr200 · Cited by 64
Self-citation
Metadata
- Authors
- Geerts, A.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Geerts, Albert
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 21
- Issue
- 03
- Pages
- 311-336
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2016498524
- Cited by
- 740
- References
- 0
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 32 · 2023: 20 · 2022: 36 · 2021: 28 · 2020: 35 · 2019: 28 · 2018: 28 · 2017: 33 · 2016: 37 · 2015: 50 · 2014: 30 · 2013: 40 · 2012: 33
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Northwest Fisheries Science Center
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- hepatic stellate cells, liver histopathology, vitamin A storage, extracellular matrix turnover, matrix metalloproteinases, liver fibrosis, space of Disse, sinusoidal blood flow, paracrine signaling, liver homeostasis
- MeSH terms
- Cell Communication, Chemotactic Factors, Extracellular Matrix, Homeostasis, Humans, Hypertension, Portal, Liver, Liver Cirrhosis, Liver Neoplasms, Regional Blood Flow, Retinoids, Vitamin A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.